Salih Şanlıoğlu

3.1k total citations
70 papers, 2.6k citations indexed

About

Salih Şanlıoğlu is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Salih Şanlıoğlu has authored 70 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Genetics and 22 papers in Immunology. Recurrent topics in Salih Şanlıoğlu's work include Virus-based gene therapy research (17 papers), Cell death mechanisms and regulation (16 papers) and Pancreatic function and diabetes (15 papers). Salih Şanlıoğlu is often cited by papers focused on Virus-based gene therapy research (17 papers), Cell death mechanisms and regulation (16 papers) and Pancreatic function and diabetes (15 papers). Salih Şanlıoğlu collaborates with scholars based in Türkiye, United States and France. Salih Şanlıoğlu's co-authors include John F. Engelhardt, Ahter Dilşad Şanlioğlu, Thomas S. Griffith, Gary W. Hunninghake, Mustafa Kemal Balcı, Lobelia Samavati, Peter K Benson, Bahri Karaçay, Hasan Altunbaş and Jusan Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Salih Şanlıoğlu

68 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salih Şanlıoğlu Türkiye 29 1.6k 821 520 356 339 70 2.6k
Sunil Nagpal United States 38 2.5k 1.6× 1.2k 1.5× 1.0k 1.9× 588 1.7× 235 0.7× 87 4.2k
Rodolfo Iuliano Italy 28 1.7k 1.1× 331 0.4× 519 1.0× 327 0.9× 211 0.6× 75 2.6k
Narin Osman Australia 36 1.7k 1.1× 370 0.5× 842 1.6× 313 0.9× 643 1.9× 90 3.5k
David A. Sweetser United States 27 1.9k 1.2× 585 0.7× 277 0.5× 412 1.2× 340 1.0× 62 3.0k
Sunshin Kim South Korea 25 1.0k 0.6× 509 0.6× 596 1.1× 237 0.7× 499 1.5× 66 2.3k
Chaker N. Adra United States 32 1.6k 1.1× 636 0.8× 649 1.2× 363 1.0× 544 1.6× 57 3.5k
Hyunjin Shin South Korea 24 2.1k 1.4× 650 0.8× 471 0.9× 420 1.2× 192 0.6× 58 3.1k
Esta Sterneck United States 33 2.4k 1.5× 557 0.7× 898 1.7× 937 2.6× 191 0.6× 57 4.1k
Henrik Laurell France 30 1.0k 0.7× 597 0.7× 317 0.6× 280 0.8× 389 1.1× 56 2.6k
Sabine Geisse Switzerland 24 1.7k 1.1× 783 1.0× 317 0.6× 242 0.7× 211 0.6× 41 2.5k

Countries citing papers authored by Salih Şanlıoğlu

Since Specialization
Citations

This map shows the geographic impact of Salih Şanlıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salih Şanlıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salih Şanlıoğlu more than expected).

Fields of papers citing papers by Salih Şanlıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salih Şanlıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salih Şanlıoğlu. The network helps show where Salih Şanlıoğlu may publish in the future.

Co-authorship network of co-authors of Salih Şanlıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Salih Şanlıoğlu. A scholar is included among the top collaborators of Salih Şanlıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salih Şanlıoğlu. Salih Şanlıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şanlioğlu, Ahter Dilşad, et al.. (2024). Gene and cell therapy of human genetic diseases: Recent advances and future directions. Journal of Cellular and Molecular Medicine. 28(17). e70056–e70056. 12 indexed citations
2.
Akıncı, Ersin, et al.. (2024). Microglia cells treated with synthetic vasoactive intestinal peptide or transduced with LentiVIP protect neuronal cells against degeneration. European Journal of Neuroscience. 59(8). 1993–2015. 2 indexed citations
3.
Bişgin, Atıl, et al.. (2022). Generation of a Beta-Cell Transplant Animal Model of Diabetes Using CRISPR Technology. Advances in experimental medicine and biology. 1409. 145–159. 2 indexed citations
5.
Balcı, Mustafa Kemal, et al.. (2020). Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes. Molecular Therapy. 29(1). 149–161. 19 indexed citations
6.
Şanlioğlu, Ahter Dilşad, et al.. (2018). High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy. Methods in molecular biology. 1879. 323–345. 9 indexed citations
7.
Şanlioğlu, Ahter Dilşad, et al.. (2018). HIV-based lentivirus-mediated vasoactive intestinal peptide gene delivery protects against DIO animal model of Type 2 diabetes. Gene Therapy. 25(4). 269–283. 13 indexed citations
8.
Şanlioğlu, Ahter Dilşad, Hasan Altunbaş, Mustafa Kemal Balcı, Thomas S. Griffith, & Salih Şanlıoğlu. (2013). Clinical utility of insulin and insulin analogs. Islets. 5(2). 67–78. 45 indexed citations
9.
Bişgin, Atıl, Arzu Didem Yalçın, Çiğdem Aydın, et al.. (2012). Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer. BMC Cancer. 12(1). 58–58. 27 indexed citations
10.
Şanlioğlu, Ahter Dilşad, Bahri Karaçay, Mustafa Kemal Balcı, Thomas S. Griffith, & Salih Şanlıoğlu. (2012). Therapeutic potential of VIP vs PACAP in diabetes. Journal of Molecular Endocrinology. 49(3). R157–R167. 34 indexed citations
11.
Köksal, İsmail Türker, Ahter Dilşad Şanlioğlu, Ömer Kutlu, & Salih Şanlıoğlu. (2010). Effects of Androgen Ablation Therapy in TRAIL Death Ligand and Its Receptors Expression in Advanced Prostate Cancer. Urologia Internationalis. 84(4). 445–451. 6 indexed citations
12.
Bişgin, Atıl, Ender Terzıoğlu, Çiğdem Aydın, et al.. (2010). TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid Arthritis. BMC Musculoskeletal Disorders. 11(1). 192–192. 21 indexed citations
13.
Yoldaş, Burçak, Cem Özer, Özlem Özen, et al.. (2010). Clinical significance of TRAIL and TRAIL receptors in patients with head and neck cancer. Head & Neck. 33(9). 1278–1284. 20 indexed citations
14.
Yazısız, Veli, et al.. (2009). CTLA‐4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. International Journal of Immunogenetics. 36(4). 245–250. 22 indexed citations
15.
Kutlu, Ömer, et al.. (2009). Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis. International Urology and Nephrology. 42(2). 393–399. 18 indexed citations
16.
Şanlioğlu, Ahter Dilşad, Ercument Dirice, Gülsüm Özlem Elpek, et al.. (2008). High Levels of Endogenous Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression Correlate With Increased Cell Death in Human Pancreas. Pancreas. 36(4). 385–393. 25 indexed citations
17.
Aslan, Mutay, et al.. (2005). Nitrotyrosine formation and apoptosis in rat models of ocular injury. Free Radical Research. 40(2). 147–153. 26 indexed citations
18.
Karaçay, Bahri, Salih Şanlıoğlu, Thomas S. Griffith, Anthony D. Sandler, & Daniel J. Bonthius. (2004). Inhibition of the NF-κB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer Gene Therapy. 11(10). 681–690. 52 indexed citations
19.
Doerschug, Kevin C., Salih Şanlıoğlu, Dawn M. Flaherty, et al.. (2002). First-Generation Adenovirus Vectors Shorten Survival Time in a Murine Model of Sepsis. The Journal of Immunology. 169(11). 6539–6545. 25 indexed citations
20.
Şanlıoğlu, Salih, Peter K Benson, & John F. Engelhardt. (2000). Loss of ATM Function Enhances Recombinant Adeno-Associated Virus Transduction and Integration through Pathways Similar to UV Irradiation. Virology. 268(1). 68–78. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026